- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.12.24 | NewAmsterdam drug shows 'unexpected' signs of protecting the heart in latest study | ||
| 09.12.24 | ASH24: Darzalex in smoldering myeloma, Merck's ADC data and Novo's sickle cell drug | ||
| 09.12.24 | Gene therapy uptake in sickle cell stays slow, despite patient interest | ||
| 09.12.24 | Dimension gets $500M to bankroll biotech's convergence with tech | ||
| 09.12.24 | Endometriosis drug research, long underfunded, confronts familiar problems in women's health | ||
| 09.12.24 | What's behind pharma's growth boost? | ||
| 09.12.24 | Why bioscience and healthcare innovators are looking to Phoenix | ||
| 09.12.24 | Clinical services organizations are critical to the future of pharma in the APAC market | ||
| 06.12.24 | With conflicts of interest in focus, Trump's pick to run FDA could face scrutiny of his own industry ties | ||
| 06.12.24 | Lilly adds to obesity drug production push with $3B investment | ||
| 06.12.24 | AstraZeneca, Daiichi build cancer drug case; Amgen invests $1B | ||
| 05.12.24 | Atlas doubles down on 'disciplined' biotech investing with latest fundraise | ||
| 05.12.24 | GSK taps a startup for shot at Alzheimer's drug | ||
| 05.12.24 | Nuvig pulls in $161M to make better immune drugs | ||
| 04.12.24 | Dewpoint, Mitsubishi partner on ALS drug in deal worth up to $480M | ||
| 04.12.24 | Atea plans Phase 3 study for hepatitis C drug after mid-stage results | ||
| 04.12.24 | Novavax sells Czech plant to Novo; Relay licenses out a cancer drug | ||
| 04.12.24 | Antag, a startup backed by Versant and Novo, joins hunt for obesity drug alternatives | ||
| 04.12.24 | UnitedHealthcare CEO Brian Thompson fatally shot in NYC | ||
| 04.12.24 | Lilly's Zepbound beats Novo's Wegovy in high-stakes obesity drug trial | ||
| 03.12.24 | Coherus, sharpening immuno-oncology focus, sells another biosimilar for over $500M | ||
| 03.12.24 | Janux impresses Wall Street with new prostate cancer drug results | ||
| 03.12.24 | Note from the Editor-in-Chief | ||
| 02.12.24 | Diabetes advocacy group discourages use of compounded GLP-1 drugs | ||
| 02.12.24 | Novocure device succeeds in pancreatic cancer study; FDA sets Cytokinetics decision date |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
